Form 4: NeueHealth EVP Tomas Orozco Reports Stock Sales to Cover Tax Obligations

EVP of Consumer Care at NeueHealth, Tomas Orozco, reports selling shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On March 7, 2025, Tomas Orozco, EVP of Consumer Care at NeueHealth, sold 620 shares of common stock at a weighted average price of $7.19 to cover tax obligations.
• The sales were not discretionary transactions.
• Orozco also exercised 2,327 restricted stock units (RSUs) on March 7, 2025.
• On March 10, 2025, Orozco sold an additional 20 shares of common stock at a weighted average price of $7.06.
• Following these transactions, Orozco directly owns 12,008 shares of NeueHealth common stock.
• The restricted stock units vested in three equal annual installments starting on March 7, 2023.

Sentiment

Score: 5

Explanation: The document reflects routine transactions related to executive compensation and tax obligations, indicating a neutral sentiment.

Industry Context

Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions. These filings are closely watched by investors to gauge management's sentiment and confidence in the company.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• The size and frequency of these sales are generally proportional to the executive's compensation package and the company's stock performance.
• Comparable companies in the healthcare sector, such as UnitedHealth Group or CVS Health, also see similar Form 4 filings from their executives.

Stakeholder Impact

• The stock sales could have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely to be minimal given the relatively small number of shares involved.
• The transactions have no direct impact on employees, customers, suppliers, or creditors.

Key Dates